Metabolic Complications of HIV and Antiretroviral Therapy: Dyslipidemia, Insulin Resistance, and Cardiovascular Disease

  • Authors: Judith S. Currier, MD, MSc; Risa Hoffman, MD, MPH (More Info)
  • Editors in Chief: Joseph J. Eron, Jr., MD; Daniel R. Kuritzkes, MD
  • Last Reviewed: 10/10/18 (What's New)

Summary

  • Diagnostic criteria for glucose disorders in HIV-infected patients on ART have been described (Table 9)[ADA 2013a; ADA 2013b]
  • Fasting, random, or oral glucose tolerance testing may be used in screening patients
  • Fasting blood glucose should be undertaken in all HIV-infected patients at entry to care, every 6-12 months thereafter, and before ART initiation

    Action required